HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiaoguang Li Selected Research

Lung Neoplasms (Lung Cancer)

1/2021Prognostic value of the baseline circulating T cell receptor β chain diversity in advanced lung cancer.
1/2020The blood cells in NSCLC and the changes after RFA.
1/2020Pneumothorax triggered by EGFR-tyrosine kinase inhibitors in three microwave ablation candidates: A review of the literature.
6/2019Intratumoral Injection of Hypertonic Glucose in Treating Refractory Pneumothorax Caused by Microwave Ablation: a Preliminary Study.
1/2018Expert consensus workshop report: Guidelines for thermal ablation of primary and metastatic lung tumors (2018 edition).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiaoguang Li Research Topics

Disease

61Neoplasms (Cancer)
01/2022 - 11/2003
13Bullous Pemphigoid (Pemphigoid)
07/2022 - 04/2014
9Infections
01/2022 - 12/2007
8Ovarian Neoplasms (Ovarian Cancer)
02/2021 - 01/2011
8Alzheimer Disease (Alzheimer's Disease)
01/2020 - 12/2010
5COVID-19
01/2022 - 05/2020
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 05/2016
5Adenocarcinoma of Lung
01/2022 - 01/2020
5Lung Neoplasms (Lung Cancer)
01/2021 - 01/2018
4Type 2 Diabetes Mellitus (MODY)
06/2022 - 01/2017
4Liver Neoplasms (Liver Cancer)
10/2021 - 08/2017
4Cataract (Cataracts)
02/2021 - 01/2018
4Fibrosis (Cirrhosis)
01/2021 - 11/2014
4Neoplasm Metastasis (Metastasis)
01/2021 - 04/2013
4Inflammation (Inflammations)
06/2019 - 06/2014
4Carcinogenesis
01/2018 - 11/2003
4Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2018 - 01/2017
3Pneumonia (Pneumonitis)
04/2022 - 01/2015
3Human Influenza (Influenza)
12/2021 - 01/2021
3Squamous Cell Carcinoma of Head and Neck
10/2021 - 03/2020
3Skin Diseases (Skin Disease)
05/2021 - 08/2013
3Breast Neoplasms (Breast Cancer)
04/2021 - 01/2013
3Pemphigus (Pemphigus Vulgaris)
01/2021 - 03/2014
3Carcinoma (Carcinomatosis)
03/2020 - 02/2015
3Spinal Cord Injuries (Spinal Cord Injury)
04/2019 - 02/2009
3Hemorrhage
01/2019 - 02/2014
3Pain (Aches)
02/2010 - 06/2004
2Insulin Resistance
01/2022 - 11/2002
2Weight Loss (Weight Reduction)
01/2022 - 12/2007
2Margins of Excision
07/2021 - 01/2021
2Lymphoma (Lymphomas)
01/2021 - 06/2013
2Disease Progression
01/2021 - 01/2020
2Hepatocellular Carcinoma (Hepatoma)
01/2020 - 01/2019
2Reperfusion Injury
01/2020 - 03/2011
2Pneumothorax
01/2020 - 06/2019
2Myocardial Ischemia (Ischemic Heart Diseases)
01/2020 - 03/2011
2Neuralgia (Stump Neuralgia)
11/2019 - 06/2011
2Hyperalgesia
11/2019 - 06/2011
2Dehydration (Water Stress)
06/2019 - 09/2013
2Hematoma
01/2019 - 07/2010
2Atrophy
06/2018 - 12/2007
2Memory Disorders (Memory Loss)
11/2017 - 01/2016

Drug/Important Bio-Agent (IBA)

15Proteins (Proteins, Gene)FDA Link
01/2022 - 02/2015
9Laminin (Merosin)IBA
07/2022 - 02/2015
8AutoantibodiesIBA
01/2022 - 03/2014
7AntigensIBA
12/2021 - 05/2014
7Pharmaceutical PreparationsIBA
01/2020 - 10/2016
6Biomarkers (Surrogate Marker)IBA
04/2022 - 01/2010
6AntibodiesIBA
01/2022 - 08/2014
6EnzymesIBA
01/2017 - 03/2011
5Biological ProductsIBA
02/2021 - 01/2011
5Capsules (Microcapsules)IBA
01/2021 - 11/2014
5Amyloid (Amyloid Fibrils)IBA
11/2017 - 12/2010
4Aryl Hydrocarbon Receptor Nuclear TranslocatorIBA
06/2022 - 01/2017
4IntegrinsIBA
01/2022 - 11/2003
4AutoantigensIBA
01/2022 - 06/2016
4Messenger RNA (mRNA)IBA
10/2021 - 11/2014
4RNA (Ribonucleic Acid)IBA
01/2021 - 09/2014
4Histone Deacetylases (Histone Deacetylase)IBA
01/2016 - 01/2015
3Matrix Metalloproteinases (MMPs)IBA
01/2022 - 04/2014
3Immunoglobulin G (IgG)IBA
01/2022 - 09/2015
3Immune Checkpoint InhibitorsIBA
01/2022 - 01/2018
3MicroRNAs (MicroRNA)IBA
10/2021 - 03/2015
3artemisinin (artemisinine)IBA
02/2021 - 12/2016
3ErbB Receptors (EGF Receptor)IBA
01/2021 - 03/2014
3CollagenIBA
04/2019 - 11/2014
3Creatine Kinase (Creatine Phosphokinase)IBA
01/2018 - 01/2010
2COVID-19 VaccinesIBA
01/2022 - 10/2021
2Interferon Type IIBA
01/2022 - 01/2019
2Glucose (Dextrose)FDA LinkGeneric
01/2022 - 06/2019
2Therapeutic UsesIBA
02/2021 - 08/2017
2Melphalan (Alkeran)FDA LinkGeneric
02/2021 - 12/2016
2Cell-Free Nucleic AcidsIBA
01/2021 - 01/2020
2AlkaloidsIBA
01/2021 - 01/2011
2kushenIBA
01/2021 - 01/2020
2AerosolsIBA
01/2021 - 01/2020
2Tyrosine Kinase InhibitorsIBA
01/2021 - 01/2020
2Protein Isoforms (Isoforms)IBA
01/2021 - 01/2015
2Sorafenib (BAY 43-9006)FDA Link
01/2020 - 08/2017
2p38 Mitogen-Activated Protein KinasesIBA
10/2019 - 03/2014
2Vitamin DFDA LinkGeneric
08/2019 - 01/2013
2Hyaluronic Acid (Hyaluronan)IBA
04/2019 - 01/2018
2Transcription Factors (Transcription Factor)IBA
03/2019 - 05/2017
2arseniteIBA
01/2019 - 10/2014
2Antineoplastic Agents (Antineoplastics)IBA
01/2019 - 11/2017
2DNA (Deoxyribonucleic Acid)IBA
01/2019 - 12/2013
2NAD (NADH)IBA
01/2019 - 08/2015
2ChitosanIBA
01/2019 - 02/2009
2Oxidoreductases (Dehydrogenase)IBA
01/2019 - 12/2010
2Indicators and Reagents (Reagents)IBA
01/2018 - 10/2014
2N-acetyl-tyrosyl-valyl-alanyl-aspartyl chloromethyl ketoneIBA
01/2018 - 01/2018

Therapy/Procedure

25Therapeutics
05/2021 - 10/2002
7Aftercare (After-Treatment)
07/2021 - 09/2011
7Drug Therapy (Chemotherapy)
01/2021 - 02/2015
3Immunotherapy
10/2021 - 01/2021
3Radiofrequency Ablation
02/2018 - 01/2015
2Salvage Therapy
01/2021 - 01/2020
2Debridement
01/2021 - 09/2011
2Cesarean Section (Caesarean Section)
08/2020 - 08/2019
2Radiotherapy
03/2020 - 01/2018